Martin Wiesenfeld

Phase II Trial of Sorafenib in Patients With Metastatic Breast Cancer Previously Exposed to Anthracyclines or Taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336

Alvaro Moreno‐Aspitia, Roscoe F. Morton, David W. Hillman et al. · Journal of Clinical Oncology · 2008 · 161 citations

Medicine, Oncology, Pharmacology +17

Prognostic Value of Proliferation, Apoptosis, Defective DNA Mismatch Repair, and p53 Overexpression in Patients With Resected Dukes' B2 or C Colon Cancer

Megan M Garrity, Lawrence J. Burgart, Michelle R. Mahoney et al. · Journal of Clinical Oncology · 2004 · 126 citations · Full text

Medicine, Oncology, Pathology +17

PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study

Steven R. Alberts, Nathan R. Foster, Roscoe F. Morton et al. · Annals of Oncology · 2005 · 105 citations · Full text

Medicine, Oncology, Pharmacology +15

Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial.

Andrew W. Maksymiuk, James R. Jett, John D. Earle et al. · Journal of Clinical Oncology · 1994 · 71 citations

Medicine, Oncology, Pharmacology +17

Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Groupphase II study

Steven R. Alberts, P. Townley, Richard M. Goldberg et al. · Annals of Oncology · 2003 · 70 citations

Medicine, Oncology, Pharmacology +12